1. Home
  2. ACU vs KPTI Comparison

ACU vs KPTI Comparison

Compare ACU & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$43.34

Market Cap

154.0M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$6.30

Market Cap

148.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
KPTI
Founded
1867
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
148.0M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ACU
KPTI
Price
$43.34
$6.30
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$22.17
AVG Volume (30 Days)
8.2K
413.6K
Earning Date
02-27-2026
02-18-2026
Dividend Yield
1.46%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
$142,530,000.00
Revenue This Year
$2.19
$3.82
Revenue Next Year
$4.55
N/A
P/E Ratio
$17.83
N/A
Revenue Growth
2.35
N/A
52 Week Low
$35.20
$3.51
52 Week High
$45.25
$10.80

Technical Indicators

Market Signals
Indicator
ACU
KPTI
Relative Strength Index (RSI) 74.24 39.97
Support Level $42.50 $7.05
Resistance Level $43.94 $8.95
Average True Range (ATR) 1.14 0.62
MACD 0.21 -0.18
Stochastic Oscillator 100.00 1.85

Price Performance

Historical Comparison
ACU
KPTI

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: